The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation
Open accessAbstract
Local increases in cyclic adenosine monophosphate (cAMP) caused by specific adenylyl cyclases (ACs) can selectively modulate related proteins. AC-selective drugs have an advantage in side effect control, and the specific AC may finally be considered as a therapeutic target. We show that adenylyl cyclase 4 (ADCY4), which is silenced by DNA methylation and is critical for breast cancer (BC) patient survival, plays essential roles in anti-tumor effects in BC cells. DNA methyltransferase inhibitor and histone deacetylase inhibitor can restore ADCY4 mRNA expression in ADCY4-silenced BC cells. ADCY4 directly affects BC cell proliferation, apoptosis, invasion, and metastasis. Mechanistically, ADCY4 converts ATP to cAMP and activates cAMP/PKA signaling, leading to a decrease in the phosphorylation level of downstream FAK/AKT and ERK signaling and creating a suppression environment for cell survival. Ectopic ADCY4 inhibits BC growth, which is blocked by cAMP inhibition, activating AKT and ERK. The present study provides evidence that human BC relies upon this epigenetic silenced ADCY4-associated ATP-cAMP loop for phosphorylation and activation of FAK/AKT and ERK signaling. Also, ADCY4 increases BC cell chemosensitivity to paclitaxel. The observations demonstrates that ADCY4 is a significant tumor suppressor and that loss of ADCY4 functions by DNA methylation hampers cAMP signaling and triggers FAK/AKT and ERK signaling during breast tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, six of the 19 prognostic genes are non-enzymatic regulators that modulate glycolytic flux via receptor signaling or transcriptional control (16–21).”
From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through literature research, six genes (WNT3A, VIPR1, ADRB2, SPRY1, PDGFB, and RXFP1) related to lung cancer and the regulation of glycolytic metabolic pathways were identified among the 19 genes.”
From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In lung cancer, glycolysis has been implicated in promoting metastatic potential by facilitating cytoskeletal remodeling and enhancing cellular motility in both murine and human models (20).”
From Bioinformatics-based identification of glycolysis-related signatures associated with drug resistance and prognosis in lung adenocarcinoma (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Sherman, B. T., Hao, M., Qiu, J., Jiao, X., Baseler, M. W., Lane, H. C., Imamichi, T., & Chang, W. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac194 · Cited by 6,142
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
CDD/SPARCLE: functional classification of proteins via subfamily domain architectures
Marchler-Bauer, A., Bo, Y., Han, L., He, J., Lanczycki, C. J., Lu, S., Chitsaz, F., Derbyshire, M. K., Geer, R. C., Gonzales, N. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1129 · Cited by 2,713
UALCAN: An update to the integrated cancer data analysis platform
Chandrashekar, D. S., Karthikeyan, S. K., Korla, P. K., Patel, H., Shovon, A. R., Athar, M., Netto, G. J., Qin, Z. S., Kumar, S., Manne, U., et al. (2022) · Neoplasia · doi:10.1016/j.neo.2022.01.001 · Cited by 2,473
Search and sequence analysis tools services from EMBL-EBI in 2022
Madeira, F., Pearce, M., Tivey, A. R. N., Basutkar, P., Lee, J., Edbali, O., Madhusoodanan, N., Kolesnikov, A., & Lopez, R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac240 · Cited by 2,267
Loibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32381-3 · Cited by 1,648
Cited by
Ding, T., Diao, Y., Fu, R., Gong, C., He, Q., He, W., Zhang, L., Yang, X., Zeng, X., Lijuan, Y., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.056 · Cited by 9
Zheng, Q., Liu, Y., Li, T., Zhang, X., Geng, Y., Chen, Z., Zhou, J., Fan, W., Wang, Y., Zhang, L., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1871582
“In lung cancer, glycolysis has been implicated in promoting metastatic potential by facilitating cytoskeletal remodeling and enhancing cellular motility in both murine and human models (20).”
Self-citationYu, C., Fang, L., Meijuan, C., Yuanli, W., & Min, F. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02080-0
Liu, L., Li, A., Guo, Q., Wen, M., Zhao, L., Tan, S., Peng, M., 孔敏, Xu, Z., Zheng, L., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-78203-z
Metadata
- Authors
- Pan, G., Huang, M., Fu, S., Wang, Y., He, L., Wu, B., Yang, J., Lin, S., & Fan, Y.
- Affiliations
- Southwest Medical University (CN)
- The First People's Hospital of Guangyuan (CN)
- Corresponding author
- Pan, Guangrui
- Venue
- Scientific Reports
- Published
- 2025-07-01
- Volume
- 15
- Issue
- 1
- Pages
- 20426-20426
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC12217726
- OpenAlex
- W4411885734
- Cited by
- 3
- References
- 62
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wu Jieping Medical Foundation (320.6750.2023-18-100)
- Sichuan Provincial Science and Technology Support Program (2022NSFSC1425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, DNA methylation, epigenetic silencing, cAMP signaling, protein kinase A, FAK/AKT signaling, ERK signaling, tumor suppressor, cell proliferation, apoptosis, metastasis, hypomethylating agents, histone deacetylase inhibitors
- MeSH terms
- Cyclic AMP, Adenylyl Cyclases, Animals, Breast Neoplasms, Female, Humans, Signal Transduction, Gene Expression Regulation, Neoplastic, Apoptosis, DNA Methylation, Gene Silencing, MAP Kinase Signaling System, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Focal Adhesion Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation. https://app.cochat.ai/papers/10.1038/s41598-025-06294-1
- The paper
- Pan, G., Huang, M., Fu, S., Wang, Y., He, L., Wu, B., Yang, J., Lin, S., & Fan, Y. (2025). ADCY4 inhibits cAMP-induced growth of breast cancer by inactivating FAK/AKT and ERK signaling but is frequently silenced by DNA methylation. Scientific Reports. https://doi.org/10.1038/s41598-025-06294-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.